Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements and Focuses
Image gallery
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews Molecular Cell Biology
UCSD-Nature Signaling Gateway
The Cell Migration Gateway
Nature Reports Stem Cells
Nature Reports Avian Flu
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Cell Biology  4, 842 - 849 (2002)
Published online: 28 October 2002; | doi:10.1038/ncb866

BID regulation by p53 contributes to chemosensitivity

Joanna K. Sax1, Peiwen Fei1, Maureen E. Murphy2, Eric Bernhard3, Stanley J. Korsmeyer4 & Wafik S. El-Deiry1

1  Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, Departments of Medicine, Pharmacology, and Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA

2  Department of Pharmacology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA

3  Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA

4  Howard Hughes Medical Institute, Departments of Pathology and Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA

Correspondence should be addressed to Wafik S. El-Deiry wafik@mail.med.upenn.edu
The role of the p53 protein (encoded by TP53) in tumour suppression relies partly on the ability of p53 to regulate the transcription of genes that are important in cell-cycle arrest and in apoptosis. But the apoptotic pathway mediated by p53 is not fully understood. Here we show that BID, a member of the pro-apoptotic Bcl-2 family of proteins, is regulated by p53. BID mRNA is increased in a p53-dependent manner in vitro and in vivo, with strong expression in the splenic red pulp and colonic epithelium of bold gamma-irradiated mice. Both the human and the mouse BID genomic loci contain p53-binding DNA response elements that bind p53 and mediate p53-dependent transactivation of a reporter gene. In addition, BID-null mouse embryonic fibroblasts are more resistant than are wild-type fibroblasts to the DNA damaging agent adriamycin and the nucleotide analogue 5-fluorouracil, both of which stabilize endogenous p53. Our results indicate that BID is a p53-responsive 'chemosensitivity gene' that may enhance the cell death response to chemotherapy.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
The role of p53 in chemosensitivity and radiosensitivity
Oncogene Reviews (20 Oct 2003)
 See all 3 matches for Reviews

RESEARCH
BRCA1 signals ARF-dependent stabilization and coactivation of p53
Oncogene Original Article (19 Nov 1999)
Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site
Oncogene Original Article (07 Apr 2000)
p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop
The EMBO Journal Article (17 Mar 2003)
Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest
Oncogene Original Article (19 Nov 1999)
 See all 35 matches for Research

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
Supplementary info
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Cell Biology
ISSN: 1465-7392
EISSN: 1476-4679
Journal home | Advance online publication | Current issue | Archive | Press releases | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy